| Nov 20 |
Guardant Health Stock Sees RS Rating Jump To 83
|
| Nov 20 |
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead
|
| Nov 18 |
Unpacking the Latest Options Trading Trends in Hims & Hers Health
|
| Nov 18 |
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
|
| Nov 16 |
Hims & Hers: Revolutionizing Telehealth And Captivating Investors - Here's Why You Should Buy
|
| Nov 15 |
Hims & Hers Health: The Amazon Curse Is Being Overstated
|
| Nov 15 |
Netflix, Five Other Gems Soar Into Profit Zones In Hot November Rally
|
| Nov 14 |
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
|
| Nov 14 |
Hims & Hers drops 22% on Amazon competition concerns (update)
|
| Nov 14 |
Stock Market Today: Chevron Breaks Out, But Biotechs Struggle As Eli Lilly Looks Like Short-Sale Play; Will American Airlines Break Out? (Live Coverage)
|
